Celsion Corporation Share Price Nasdaq
Equities
US15117N4043
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
13/05 | Transcript : Imunon, Inc., Q1 2024 Earnings Call, May 13, 2024 | |
08/05 | IMUNON, Inc. Appoints Stacy R. Lindborg as Chief Executive Officer, Effective May 13, 2024 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 13.25M 1.11B |
---|---|---|---|---|---|
Net income 2024 * | -20M -1.67B | Net income 2025 * | -25M -2.09B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.72
x | P/E ratio 2025 * |
-0.55
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.84% |
Latest transcript on Celsion Corporation
Managers | Title | Age | Since |
---|---|---|---|
Stacy Lindborg
CEO | Chief Executive Officer | 53 | 04/21/04 |
Michael Tardugno
CHM | Chairman | 73 | 03/07/03 |
Jeffrey Church
DFI | Director of Finance/CFO | 67 | 06/10/06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 08/21/08 | |
Frederick Fritz
BRD | Director/Board Member | 73 | 08/11/08 |
James Dentzer
BRD | Director/Board Member | 57 | 03/22/03 |
1st Jan change | Capi. | |
---|---|---|
+7.52% | 113B | |
+11.38% | 106B | |
+0.82% | 22.27B | |
-12.64% | 22.22B | |
-4.59% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+7.77% | 14.29B | |
+37.41% | 12.52B |